Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Giovanni B. Frisoni, Cristina Festari, Federico Massa, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 302-312
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 7
Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for primary care
Alireza Atri, Bradford C. Dickerson, Carolyn Clevenger, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 6
Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study
Verónica Cabreira, Jane Alty, Sonja Antić, et al.
European Journal of Neurology (2024) Vol. 32, Iss. 1
Open Access | Times Cited: 5
Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes
Amy B. Karger, Ilya M. Nasrallah, Barbara H. Braffett, et al.
Diabetes Care (2024) Vol. 47, Iss. 9, pp. 1530-1538
Open Access | Times Cited: 5
The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for specialty care
Bradford C. Dickerson, Alireza Atri, Carolyn Clevenger, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 5
Plasma p‐tau217 and neurofilament/p‐tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration
Alberto Benussi, Hanna Huber, Kübra Tan, et al.
Alzheimer s & Dementia (2025)
Open Access
Lecanemab approval in EU: what should we be ready for?– the EANM perspective
Igor Yakushev, Antoine Verger, Matthias Brendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study
Théodore Decaix, François Mouton‐Liger, Julien Dumurgier, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100009-100009
Open Access
Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use
Michael Schöll, Agathe Vrillon, Takeshi Ikeuchi, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100056-100056
Open Access
Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study
Fausto Roveta, Elisa Rubino, Andrea Marcinnò, et al.
Journal of Alzheimer s Disease (2025)
Open Access
A new paradigm for neurodegenerative diseases classification: A clinical perspective
Alexandros Giannakis, Spiridon Konitsiotis
Journal of Clinical Neuroscience (2025) Vol. 134, pp. 111099-111099
Closed Access
Clinical and metabolic profiles in behavioural frontotemporal dementia: impact of age at onset
Mattia Losa, Sara Garbarino, A. Cirone, et al.
Cortex (2025) Vol. 185, pp. 84-95
Open Access
Alpha Rhythm and Alzheimer’s Disease: Has Hans Berger’s Dream Come True?
Claudio Babiloni, Xianghong Arakaki, Sandra Báez, et al.
Clinical Neurophysiology (2025) Vol. 172, pp. 33-50
Open Access
Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
Adam H. Dyer, Jean Dunne, Helena Dolphin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access
Qualitative analytics from stakeholder perspective describes the biopsychosocial model for patient-centred approach to managing psychiatric ailments
Abhishek Cukkemane, Rene Hurlemann, Veralia Gabriela Sánchez
Journal of Affective Disorders Reports (2025), pp. 100893-100893
Open Access
Event-related potential markers of subjective cognitive decline and mild cognitive impairment during a sustained visuo-attentive task
Alberto Arturo Vergani, Salvatore Mazzeo, Valentina Moschini, et al.
NeuroImage Clinical (2025) Vol. 45, pp. 103760-103760
Open Access
Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer’s disease
Friederike Völter, Sebastian Eckenweber, Maximilian Scheifele, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders
Verónica Cabreira, Jane Alty, Sonja Antić, et al.
BMJ Neurology Open (2025) Vol. 7, Iss. 1, pp. e000918-e000918
Open Access
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
Antoine Leuzy, Ariane Bollack, Daniela Pellegrino, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Temporal Changes in Alzheimer's Disease‐Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study
Weiwei Li, Dong‐Yu Fan, Qi Sun, et al.
Aging Cell (2025)
Open Access
The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
Simone Salemme, Flavia Lombardo, Eleonora Lacorte, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access
Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis
Hadrien M. Lalive, Alessandra Griffa, Lorenzo Pini, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
For a dementia diagnosis, clinical acumen must precede biomarkers
David S. Knopman
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 225-226
Closed Access | Times Cited: 4
Dementia
Esther S. Oh
Annals of Internal Medicine (2024) Vol. 177, Iss. 11, pp. ITC161-ITC176
Closed Access | Times Cited: 3
The Bayesian approach for real‐world implementation of plasma p‐tau217 in tertiary care memory clinics in Thailand
Poosanu Thanapornsangsuth, Kittithatch Booncharoen, Jedsada Khieukhajee, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6456-6467
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top